MORITA Kunihiko 森田邦彦

Researcher Number	80327717
Other IDs
External Links
Affiliation (Current)	2021: 同志社女子大学, 薬学部, 教授
Affiliation (based on the past Project Information) *help	2000 – 2004: 慶應義塾大学, 医学部, 助教授
Review Section/Research Field	Principal Investigator 応用薬理学・医療系薬学 / Medical pharmacy Except Principal Investigator 応用薬理学・医療系薬学 / Biological Sciences / General surgery
Keywords	Principal Investigator CRP / 薬物血中濃度モニタリング / カルバペネム系抗生物質 / アミノグリコシド系抗生 / グリコペプチド系抗生物質 / 薬物血中濃度モニタリン / ピーク血中濃度 / トラフ血中濃度 / 治療効果 / メロペネム … More Except Principal Investigator CYP2C9 / 薬物代謝酵素 / CYP3A5 / ワルファリン / 遺伝子変異多型 / TaqManPCR法 / 薬物血中濃度 / 遺伝子診断 / CYP2D6 / S-1 / TaqMan PCR法 / CYP3A4 / genotyping / CYP2C93 / シクロスポリン / 生体肝移植 / 6β-水酸化コルチゾール / liver transplantation / 血液凝固 / 凝固系第VII因子 / 抗がん剤 / Pharmacokinetics / ドセタキセル / CYP3A5^3 / 薬物動態 / Population Pharmacokinetics / TS-1 / 5-FU / 薬物血中濃度モニタリング / anticancer drug / pharmacokinetics / drug metabolizing enzyme / docetaxel / フルバスタチン / HMG-CoA還元酵素阻害剤 / 遺伝子多型 / 血栓症治療 / 高コレステロール血症治療 / fluvastatin / HMG-CoA reductase inhibitor / 免疫抑制剤 / 心移植 / 肝移植 / 小腸移植 / バイオマーカー / DNAマイクロアレイ / プロテインチップ / 心臓移植モデル / 小腸移植モデル / 拒絶反応バイオマーカー / 網羅的解析 / シクロスポリンA / CYP3A / コルチゾール / 拒絶反応 / immunosuppressive agents / cardiac transplantation / small bowel transplantation / biomarker / DNA microarray / protein chip / 拒絶マーカー / シクロスポリン代謝物 / 6β-OHF / F比 / 急性拒絶反応 / CYP 3 A4 / 内因性コルチゾール / 肝臓移植 / サイクロスポリン / CYP3A activity / 6B-hydroxycortisol / cyclosporin / marker of rejection / metabolites of cyclosporin / GB-OHF / F ratio / acute cellular rejection Less

Serum cystatin C as a new marker for determining the optimal dosage of renally excreted drugs.Principal Investigator
- Principal Investigator
  
  MORITA Kunihiko
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Keio University
Development of rational immunosuppressive therapy in organ transplantation based on pharmacogenomic and proteomic research
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  2002 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  Keio University
optimal immunosuppression after organ transplantation from the view point of CYP3A activity
- Principal Investigator
  
  HOSHINO Ken
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  KEIO UNIVERSITY
Optimization of Antibiotic Chemotherapy Based on Pharmacokinetics and Phannacodynamics of Antibiotics in Patients with Severe InfectionsPrincipal Investigator
- Principal Investigator
  
  MORITA Kunihiko
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  Keio University
CYP2C9の遺伝子診断に基づく抗凝固薬物療法の個別化
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  2000
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (C)
- Review Section
  
  Biological Sciences
- Research Institution
  Keio University
Development of Drug Monitoring System in Determining Optimal Dosage of Anticancer Drugs
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  2000 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  Keio University
Multiple analysis concerning therapeutic significance of drug-metabolizing enzyme CYP2C9 polymorphism
- Principal Investigator
  
  TANIGAWARA Yusuke
- Project Period (FY)
  2000 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  応用薬理学・医療系薬学
- Research Institution
  Keio University

All 2005 2004 2003

All Journal Article

[Journal Article] Serum cystatin C as a new marker for determining the optimal dosage of renally excreted drugs.2005
- Author(s)
  O.Iketani, K.Morita et al.
- Journal Title
  
  The Keio Journal of Medicine 54
  
  Pages: 39-39
- NAID
  10015422632
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590138
[Journal Article] 抗菌薬のPK/PDと透析患者への適正投与法2005
- Author(s)
  森田邦彦
- Journal Title
  
  透析会誌 38
  
  Pages: 97-98
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590138
[Journal Article] Serum cystatin C as a new marker for determining the optimal dosage of renally wxcreted drugs.2005
- Author(s)
  Iketani O, Morita K et al.
- Journal Title
  
  The Keio Journal of Medicine 54
  
  Pages: 39-39
- Data Source
  KAKENHI-PROJECT-15590138
[Journal Article] Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.2004
- Author(s)
  Inoue M, Morita K et al.
- Journal Title
  
  Am J Ophthalmol. 138
  
  Pages: 1046-1048
- Data Source
  KAKENHI-PROJECT-15590138
[Journal Article] PK/PDからみた抗菌薬適正使用の実際2004
- Author(s)
  森田邦彦
- Journal Title
  
  月刊薬事 46(12)
  
  Pages: 2157-2163
- Data Source
  KAKENHI-PROJECT-15590138
[Journal Article] 新しい腎機能マーカー・血清シスタチンC濃度を用いた腎排泄型薬物投与設計の有用性2003
- Author(s)
  池谷修, 森田邦彦ほか
- Journal Title
  
  臨床薬理 34
- NAID
  10011422193
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590138
[Journal Article] Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats2003
- Author(s)
  H.Konishi, K.Morita et al.
- Journal Title
  
  J.Pharm.Pharmacol. 55
  
  Pages: 143-149
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590138
[Journal Article] カルバペネム系抗生物質・メロペネムの血中濃度と臨床効果との関係解析2003
- Author(s)
  森田邦彦ほか
- Journal Title
  
  TDM研究 20
  
  Pages: 189-190
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590138
[Journal Article] Depression of phenytoin metabolic capacity by 5-fluorouradil and doxifluridine in rats2003
- Author(s)
  H.Konishi, K.Morita et al.
- Journal Title
  
  J.Pharm.Pharmacol. 55
  
  Pages: 143-149
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590138

1. TANIGAWARA Yusuke (30179832)

# of Collaborated Projects: 6 results

# of Collaborated Products: 0 results
2. TANABE Minoru (50197513)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
3. 村田満 (50174305)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. KOBAYASHI Yoshio (80118950)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. SHIMAZU Motohide (70124948)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. HOSHINO Ken (70190197)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. MORIKAWA Yasuhide (90124958)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. SHIMOJIMA Naoki (30317151)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. WATANABE Roshihiko (50306734)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. ASANO Koichiro (60192944)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 山口佳寿博 (30129712)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

MORITA Kunihiko 森田 邦彦

Research Projects

Research Products

Co-Researchers

Serum cystatin C as a new marker for determining the optimal dosage of renally excreted drugs.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of rational immunosuppressive therapy in organ transplantation based on pharmacogenomic and proteomic research

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

optimal immunosuppression after organ transplantation from the view point of CYP3A activity

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Optimization of Antibiotic Chemotherapy Based on Pharmacokinetics and Phannacodynamics of Antibiotics in Patients with Severe InfectionsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

CYP2C9の遺伝子診断に基づく抗凝固薬物療法の個別化

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Drug Monitoring System in Determining Optimal Dosage of Anticancer Drugs

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Multiple analysis concerning therapeutic significance of drug-metabolizing enzyme CYP2C9 polymorphism

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Serum cystatin C as a new marker for determining the optimal dosage of renally excreted drugs.2005

Author(s)

Journal Title

NAID

Description

Data Source

[Journal Article] 抗菌薬のPK/PDと透析患者への適正投与法2005

Author(s)

Journal Title

Description

Data Source

[Journal Article] Serum cystatin C as a new marker for determining the optimal dosage of renally wxcreted drugs.2005

Author(s)

Journal Title

Data Source

[Journal Article] Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.2004

Author(s)

Journal Title

Data Source

[Journal Article] PK/PDからみた抗菌薬適正使用の実際2004

Author(s)

Journal Title

Data Source

[Journal Article] 新しい腎機能マーカー・血清シスタチンC濃度を用いた腎排泄型薬物投与設計の有用性2003

Author(s)

Journal Title

NAID

Description

Data Source

[Journal Article] Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats2003

Author(s)

Journal Title

Description

Data Source

MORITA Kunihiko 森田邦彦